Glassman Wealth Services Chemo Centryx, Inc. Transaction History

Glassman Wealth Services

  • $585 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 23, 2022
SELL
$22.22 - $39.12 $333 - $586
-15 Reduced 39.47%
23 $1,000
Q4 2021

Feb 14, 2022
BUY
$18.38 - $40.5 $275 - $607
15 Added 65.22%
38 $1,000
Q2 2021

Aug 04, 2021
SELL
$9.59 - $50.88 $86 - $457
-9 Reduced 28.13%
23 $0
Q3 2020

Nov 09, 2020
BUY
$46.35 - $61.69 $1,483 - $1,974
32 New
32 $2,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email